Fremanezumab for the Prevention of Menstrually-related Migraine Attacks

Clinical trial NCT06659120 · RECRUITING

Trial details

NCT number: NCT06659120
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: RECRUITING
Study type: OBSERVATIONAL

Menstrual Migraine

Start date: 2024-04-09
Primary completion: 2026-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.